跳至主要内容
临床试验/NCT07059598
NCT07059598已完成不适用

Evaluate the Relationship of Nutritional Status to Chemotherapy Treatment Completion Rates and Outcomes in Real-life Conditions in Patients With Metastatic and Non-metastatic Gastric, Colon, and Lung Cancer.

Abbott Nutrition13 个研究点 分布在 1 个国家目标入组 209 人开始时间: 2022年8月12日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
209
试验地点
13
主要终点
RMAPP

研究概览

简要总结

This non-interventional, prospective, non-drug observational study is designed to observe the effect of the nutritional status of metastatic and non-metastatic gastric, colon and lung cancer patients on their cancer chemotherapy treatment completion rates.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject or subject's legally acceptable representative (LAR) has voluntarily signed and dated an ICF approved by an IEC, or any other applicable privacy authorization prior to any participation in the study.
  • Ambulatory and inpatient subject.
  • Subject recently (within the last month) or newly diagnosed to have metastatic or non-metastatic gastric, colon and lung cancer.
  • Subject is recently receiving chemotherapy or recently prescribed to begin chemotherapy treatment per standard of care (within the last month) or candidates who will receive chemotherapy.
  • Subject has a life expectancy greater than 6 months.

排除标准

  • Subject has known dementia, brain metastases, eating disorders, history of significant neurological or psychiatric disorder, any other psychological condition, serious illness or medical condition that may interfere with study completion.
  • Subject has malignant tumors other than treated DCIS, fully treated non-melanoma skin cancer, curatively resected in-situ cervical cancer or other curative treated tumors (except stomach, colon and lung cancer) for > 5 years.
  • Subject has bone marrow metastasis.
  • Subject is lactating.
  • Subject is participating in another study that has not been approved as a concomitant study.

结局指标

主要结局

RMAPP

时间窗: Baseline to week 24

A tool to screen patients for risk of malnutrition and/or sarcopenia

PG-SGA

时间窗: Baseline to week 24

Healthcare Professional completed assessment resulting in score where A = Well Nourished, B = Moderately Malnourished, and C = Severely Malnourished

次要结局

  • Weight(Baseline to 24 weeks)
  • Height(Baseline)
  • Calf Circumference(Baseline to 24 weeks)
  • Fat Free Mass Index(Baseline to week 24)
  • EORTC QLQ-C30(Baseline to 12 months)
  • Body Mass Index(Baseline to week 24)
  • Handgrip Strength(Baseline to 24 weeks)
  • Walking Speed(Baseline to 24 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (13)

Loading locations...

相似试验